-
NMPA Approves Shenzhen Mindray’s Innovative Dual-Mode Ultrasound Diagnostic System
•
The National Medical Products Administration (NMPA) has granted approval to Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) for its innovative ultrasound diagnostic system, as announced on the bureau’s website. Introducing the First Dual-Mode Imaging Product in ChinaThe approved product is hailed as China’s first dual-mode imaging product, integrating both…
-
Mindray Reports Q3 2024 Financials: International Revenues Surge Over 18% Amid Domestic Challenges
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE: 300760) reported its Q3 2024 financial results, revealing revenues of RMB 29.48 billion (USD 4.18 billion) for the first three quarters, reflecting a year-on-year increase of 7.99%. Net profit attributable to the parent company reached RMB 10.64 billion (USD 1.49 billion), up 8.16%…
-
Mindray Bio-Medical Partners with Nanjing Drum Tower Hospital to Boost Clinical Research
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical equipment provider, has entered into a partnership with Nanjing Drum Tower Hospital, a prestigious and historically significant hospital in China. The collaboration will focus on key medical disciplines of the hospital and involve clinical study cooperation as part of…
-
Mindray Bio-Medical Electronics Reports 11.12% YOY Revenue Growth in 2024H1
•
SHENZHEN—Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has announced its financial results for the first half of 2024, with revenues reaching RMB 20.53 billion, marking an 11.12% year-on-year increase. The net profit saw a robust rise, climbing to RMB 7.56 billion, which is a 17.37% increase. Despite a 7.59% YOY…
-
Mindray Medical Forges Comprehensive Partnership with CUHK-Shenzhen School of Medicine
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a prominent medical device company based in China, has entered into a strategic partnership with the CUHK-Shenzhen School of Medicine. The collaboration aims to foster comprehensive and in-depth cooperation across various domains, including industrial-university research, international academic exchanges, and talent development. The…
-
Mindray Bio-Medical Partners with Nanjing Municipal Government to Boost Healthcare Innovation
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading player in the global medical device market, has entered into a strategic partnership with the municipal government of Nanjing. This collaboration aims to drive an extensive, multi-tiered, and broad application of scientific research achievements within the healthcare sector, enhancing both…
-
Mindray Bio-Medical Electronics Reports 15.04% YOY Revenue Growth in 2023 Financial Results
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has announced its financial results for 2023, with revenues reaching RMB 34.932 billion (USD 4.82 billion), reflecting a robust year-on-year (YOY) growth of 15.04%. Net profits for the medical equipment manufacturer surged to RMB 11.58 billion (USD 1.6 billion), marking an increase…
-
Mindray to Acquire 21.12% Stake in APT Medical for RMB 6.652 Billion
•
Mindray (SHE: 300760), a leading China-based medtech firm, has announced plans to acquire a 21.12% stake in APT Medical Inc., a Shenzhen-based specialist in cardiac electrophysiology that went public on Shanghai’s STAR market in 2021. The acquisition will cost Mindray approximately RMB 6.652 billion (USD 926.6 million). Additionally, Mindray will…
-
Mindray Bio-Medical Electronics Posts Strong Q1-Q3 2023 Financial Results
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has revealed a robust financial performance for the Q1-Q3 2023 period. The company generated RMB 27.3 billion (USD 3.74 billion) in revenues during the first three quarters, marking a 17.2% year-on-year (YOY) increase. This growth underscores Mindray’s strong market position and effective…
-
Mindray Launches TE Air Wireless Handheld Ultrasound Solution in the US Market
•
China-based global device giant Mindray (SHE: 300760) has announced the market launch of its TE Air Wireless Handheld Ultrasound imaging solution in the United States. This innovative device offers healthcare providers (HCPs) a pocket-held scanning tool designed for use across a broad spectrum of clinical scenarios, enhancing diagnostic capabilities at…
-
Mindray Bio-Medical Electronics to Acquire Majority Stake in DiaSys Diagnostic Systems
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical device company based in China, is poised to acquire a 75% controlling stake in Germany-headquartered in vitro diagnostics (IVD) specialist DiaSys Diagnostic Systems GmbH. The transaction is valued at EUR 115 million (USD 127 million), marking a significant move…
-
Shanghai Pharmaceuticals and Mindray Form Strategic Alliance for Medical Equipment and IVD Products
•
Shanghai Pharmaceuticals (SHA: 601607, HKG: 2607), a leading pharmaceutical company in China, has announced a long-term partnership with fellow Chinese medical device firm Mindray (SHE: 300760). The collaboration will focus on medical equipment, medical consumables, and in vitro diagnostic (IVD) products. The two companies plan to integrate their existing resources…
-
Mindray Partners with Vazyme Biotech to Develop Automated Infection Screening Solutions
•
China-based medical device company Mindray (SHE: 300760) has entered into a partnership with fellow Chinese firm Vazyme Biotech Co., Ltd. (SHA: 688105). The collaboration aims to develop a comprehensive automated solution for infection screening and respiratory pathogen detection. Advancing Diagnostic Capabilities with AutomationThe partnership will leverage the combined expertise of…
-
Mindray Reports Strong YOY Growth in 2022 and Q1 2023 Financial Results
•
China-based medical device firm Mindray (SHE: 300760) has released its financial reports for the year 2022 and the first quarter of 2023, showcasing robust growth across its main business units. In 2022, the company recorded a revenue of RMB 30.366 billion (USD 4.4 billion), marking a 20.17% increase year-on-year (YOY),…
-
Mindray Launches First Wireless Handheld Ultrasound System, TE Air
•
China-based medical device firm Mindray (SHE: 300760) has announced the market launch of the firm’s first wireless handheld ultrasound system, branded TE Air. This innovative device represents a historic breakthrough in image quality, integrating professional-level imaging into a compact and lightweight wireless system for ease of use in various medical…
-
Mindray Bio-Medical’s H1 2022 Revenues Jump 20.17% to RMB 15.3B
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) reported robust financial results for H1 2022, with revenues reaching RMB 15.3 billion (USD 2.24 billion), up 20.17% year-on-year (YOY). Net profits rose 21.71% YOY to RMB 5.28 billion (USD 773 million). Business Segments R&D InvestmentMindray invested RMB 1.45 billion (USD 212…
